HLA-G and susceptibility to develop celiac disease

Human Immunology

Volumn 76, Issue 1, 2015, Pages 36-41

  Catamo, Eulalia ^a   Zupin, Luisa ^b   Segat, Ludovica ^b   Celsi, Fulvio ^b   Crovella, Sergio ^a,b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Celiac disease; Human Leukocyte Antigen (HLA) G; Inflammation; MRNA stability

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA; GENOMIC DNA; HLA G ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; THYMOCYTE ANTIBODY; HLA DQ ANTIGEN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; GLUTEN FREE DIET; HAPLOTYPE; HLA TYPING; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RETROSPECTIVE STUDY; RNA STABILITY; SEROLOGY; YOUNG ADULT; ALLELE; CASE CONTROL STUDY; CHILD; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CELIAC DISEASE; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-G ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES;

EID: 84920846989     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.12.006     Document Type: Article

References (49)

1. Klein J., Sato A. The HLA system. First of two parts. N Engl J Med 2000, 343:702-709.
2. Klein J., Sato A. The HLA system. Second of two parts. N Engl J Med 2000, 343:782-786.
3. Carosella E.D., Moreau P., Le Maoult J., Le Discorde M., Dausset J., Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003, 81:199-252.
4. Carosella E.D., Moreau P., Lemaoult J., Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008, 29:125-132.
5. Urosevic M., Dummer R. HLA-G and IL-10 expression in human cancer-different stories with the same message. Semin Cancer Biol 2003, 13:337-342.
6. Onno M., Pangault C., Le Friec G., Guilloux V., André P., Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000, 164:6426-6434.
7. Lozano J.M., Gonzàles R., Kindelàn J.M., Rouas-Freiss N., Caballos R., Dausset J., et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002, 16:347-351.
8. Carosella E.D., Moreau P., Aractingi S., Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol 2001, 22:553-555.
9. Torres M.I., Le Discorde M., Lorite P., Rìos A., Gassull M.A., Gil A., et al. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. Int Immunol 2004, 16:579-583.
10. Pangault C., Le Friec G., Caulet-Maugendre S., Léna H., Amiot L., Guilloux V., et al. Lung macrophages and dendritic cells express HLA-G molecules in pulmonary disease. Hum Immunol 2002, 63:83-90.
11. Rosado S., Perez-Chacon G., Mellor-Pita S., Sanchez-Vegazo I., Bellas-Manendez C., Citores M.J., et al. Expression of human leukocyte antigen-G in systemic lupus erythematosus. Hum Immunol 2008, 69:9-15.
12. Veit T.D., Cordero E.A., Mucenic T., Monticielo O.A., Brenol J.C., Xavier R.M., et al. Association of the HLA-G 14bp polymorphism with systemic lupus erythematosus. Lupus 2009, 18:424-430.
13. Cordero E.A., Veit T.D., da Silva M.A., Jacques S.M., Silla L.M., Chies J.A. HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 2009, 74:308-313.
14. Glas J., Torok H.P., Tonenchi L., Wetzke M., Beynon V., Teshome M.Y., et al. The 14bp deletion polymorphism in the HLA-G gene display significant difference between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn'disease. Int Immunol 2007, 16:621-626.
15. Castelli E.C., Mendes-Junior C.T., Viana de Camargo J.L., Donadi E.A. HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens 2008, 72:149-157.
16. Crispim J.C., Mendes-Junior C.T., Wastowski I.J., Costa R., Castelli E.C., Saber L.T., et al. Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome. Tissue Antigens 2008, 71:35-41.
17. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997, 94:11520-11525.
18. Riteau B., Menier C., Khalil-Daher I., Sedlik C., Dausset J., Rouass-Freiss N., et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999, 43:203-211.
19. LeMaoult J., Caumartin J., Daouya M., Favier B., Le Rond S., Gonzalez A., et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007, 109:2040-2048.
20. Horuzsko A., Lenfant F., Munn D.H., Mellor A.L. Maturation of antigen presenting cells is compromised in HLA-G transgenic mice. Int Immunol 2001, 13:385-394.
21. Carosella E.D., HoWangYin K.Y., Favier B., LeMaoult J. HLA-G dependent suppressor cells: diverse by nature, function, and significance. Hum Immunol 2008, 69:700-707.
22. Fons P., Chabot S., Cartwright J.E., Lenfant F., L'Faqihi F., Giustiniani J., et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006, 108:2608-2615.
23. Qiao S.W., Sollid L.M., Blumberg R.S. Antigen presentation in celiac disease. Curr Opin Immunol 2009, 21:111-117.
24. Karell K., Louka A.S., Moodie S.J., Ascher H., Clot F., Greco L., et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European genetics cluster on celiac disease. Hum Immunol 2003, 64:469-477.
25. Dieterich W., Esslinger B., Schuppan D. Pathomechanisms in celiac disease. Int Arch Allergy Immunol 2003, 132:98-108.
26. Sollid L.M. Coeliac disease: dissecting a complex inflammatory disordes. Nat Rev Immunol 2002, 2:647-655.
27. Torres M.I., Lopez Casado M.A., Rios A. New aspects in celiac disease. World J Gastroenterol 2007, 13:1156-1161.
28. Fabris A., Segat L., Catamo E., Morgutti M., Vendramin A., Crovella S. HLA-G 14bp deletion/insertion polymorphism in celiac disease. Am J Gastroenterol 2011, 106:139-144.
29. Walker-Smith J.A., Guandalini S., Schmitz J., Shmerling D.H., Visakorpi J.K. Revised criteria for diagnosis of coeliac disease. Report of working group of European society of paediatric gastroenterology and nutrition. Arch Dis Child 1990, 65:909-911.
30. Kaukinen K., Mäki M., Partanen J., Sievanen H., Collin P. Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci 2001, 46:879-888.
31. Järvinen T.T., Collin P., Rasmussen M., Kyronpalo S., Maki M., Partanen J., et al. Villous tip intraepithelial lymphocytes as markers of early-stage celiac disease. Scand J Gastroenterol 2004, 39:428-433.
32. Gomez-Casado E., Martinez-Lasot J., Castro M.J., Morales P., Trapaga J., Berciano M., et al. Detection of HLA-E and -G DNA alleles for population and disease studies. Cell Mol Life Sci 1999, 56:356-362.
33. Excoffier L., Laval G., Schneider S. Arlequin ver 3.0: an integrated software package for population genetics data analysis. Evol Bioinform Online 2005, 1:47-50.
34. Donadi E.A., Castelli E.C., Arnaiz-Villena A., Roger M., Rey D., Moreau P. Implications of the polymorphism of HLA-G on its functions, regulation, evolution and disease association. Cell Mol Life Sci 2011, 68:369-395.
35. Tan Z., Shon A.M., Ober C. Evidence of balancing selection at the HLA-G promoter region. Hum Mol Genet 2005, 14:3619-3628.
36. Ober C., Billstrand C., Kuldanek S., Tan Z. The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells. Hum Reprod 2006, 21:1743-1748.
37. Hviid T.V., Rizzo R., Christiansen O.B., Melchiorri L., Lindhard A., Baricordi O.R. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004, 56:135-141.
38. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella E.D., Moreau P. The 14bp deletion-insertion polymorphism in the 3'UT region of the HLA-G gene influences HLA-G. Hum Immunol 2003, 64:1005-1010.
39. Yie S.M., Li L.H., Xiao R., Librach C.L. A single base-pair mutation in the 3'-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod 2008, 14:649-653.
40. Hviid T.V., Hylenius S., Rorbye C., Nielsen L.G. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003, 55:63-79.
41. Rebmann V., van der Ven K., Passler M., Pfeiffer K., Krebs D., Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001, 57:15-21.
42. Castelli E.C., Mendes-Junior C.T., Deghaide N.H.S., de Albuquerque R.S., Muniz Y.C., Simoes R.T., et al. The genetic structure of 3' untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun 2010, 11:134-141.
43. Larsen M.H., Hviid T.V. Human leukocyte antigen-G polymorphism in relation to expression, function, and disease. Hum Immunol 2009, 70:1026-1034.
44. Di Cristofaro J., El Moujally D., Agnel A., Mazières S., Cortey M., Basire A., et al. HLA-G haplotype structure shows good conservation between different populations and good correlation with high, normal and low soluble HLA-G expression. Hum Immunol 2013, 74:203-206.
45. Suryanarayana V., Rao L., Kanakavalli M., Padmalatha V., Raseswari T., Deenadayal M., et al. Association between novel HLA-G genotypes and risk of recurrent miscarriages: a case-control study in a south indian population. Reprod Sci 2008, 15:817-824.
46. LeMaoult J., Krawice-Radanne I., Dausset J., Carosella E.D. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci U S A 2004, 101:7064-7069.
47. Fournel S., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000, 164:6100-6104.
48. Castelli E.C., Veiga-Castelli L.C., Yaghi L., Moreau P., Donadi E.A. Transcriptional and posttranscriptional regulations of the HLA-G gene. J Immunol Res 2014, 2014:734068.
49. Castelli E.C., Mendes-Junior C.T., Veiga-Castelli L.C., Roger M., Moreau P., Donadi E.A. A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Mol Biol Evol 2011, 28:3069-3086.